ImpediMed (IPD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IPD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period ImpediMed Full Year 2025 Earnings: EPS Misses ExpectationsAugust 29, 2025 | finance.yahoo.comImpediMed (ASX:IPD) shareholders have endured a 48% loss from investing in the stock five years agoAugust 14, 2025 | finance.yahoo.comImpediMed Director Increases Stake Through Share IssuanceAugust 1, 2025 | tipranks.comHealth Check: Lumos shares 150pc brighter after company-making US diagnostics dealJuly 15, 2025 | msn.comImpedimed Stock Price History - Investing.comJuly 9, 2025 | investing.comImpediMed Limited Updates Business AddressJune 30, 2025 | tipranks.comIs ImpediMed (ASX:IPD) In A Good Position To Deliver On Growth Plans?May 21, 2025 | finance.yahoo.comHealth Check: Impedimed says ‘nuts’ to tariffs as it squirrels away componentsApril 30, 2025 | msn.comImpediMed Achieves Record Revenue and Strengthens Sales LeadershipApril 29, 2025 | tipranks.comImpediMed Director Increases Stake with Share-Based CompensationApril 27, 2025 | tipranks.comImpediMed to Release Quarterly Results and Host Investor CallApril 16, 2025 | tipranks.comImpediMed Unaffected by New U.S. TariffsApril 8, 2025 | tipranks.com“Accelerate Action” to boost women’s leadership in Aussie healthcare sectorMarch 7, 2025 | msn.comHealth Check: Percheron ‘closes the book’ on failed childhood rare disease programFebruary 6, 2025 | msn.comImpediMed Secures $15M Growth Capital to Drive ExpansionFebruary 5, 2025 | tipranks.comImpediMed (ASX:IPD) investors are sitting on a loss of 72% if they invested three years agoFebruary 5, 2025 | finance.yahoo.comImpediMed Limited Reports Director’s Share AcquisitionJanuary 31, 2025 | tipranks.comImpediMed Leads Our Trio Of ASX Penny Stock HighlightsJanuary 9, 2025 | finance.yahoo.comImpediMed Limited Increases Director’s ShareholdingDecember 25, 2024 | markets.businessinsider.comImpediMed Alters Director’s Stock Holdings StrategyDecember 24, 2024 | markets.businessinsider.comImpedimed Director Boosts Shareholding with Fee ConversionDecember 24, 2024 | markets.businessinsider.com3 ASX Penny Stocks With Market Caps Larger Than A$30MDecember 9, 2024 | uk.finance.yahoo.comWe Think ImpediMed (ASX:IPD) Needs To Drive Business Growth CarefullyDecember 6, 2024 | uk.finance.yahoo.comImpediMed Limited Aims to Set New Standard of CareNovember 20, 2024 | markets.businessinsider.comImpediMed Limited Focuses on Commercial Growth StrategyNovember 19, 2024 | markets.businessinsider.comImpediMed Limited’s AGM Resolutions Signal Strategic GrowthNovember 19, 2024 | markets.businessinsider.comImpediMed Limited Showcases Innovations at Bell PotterNovember 18, 2024 | markets.businessinsider.comImpedimed Limited Issues Shares to ExecutivesNovember 4, 2024 | markets.businessinsider.comScott Power: Which ASX health stocks reaffirm FY25 guidance?October 25, 2024 | msn.comImpediMed Limited Presents at Major ConferenceOctober 24, 2024 | markets.businessinsider.comHealth Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitabilityOctober 10, 2024 | msn.comMarket Highlights: Fed hints at more rate cuts, gold hits highs, and all eyes on RBA todaySeptember 24, 2024 | msn.comHealthInvest 2024: The biotech sector looks in rude health, judging by these five ASX innovatorsSeptember 23, 2024 | msn.comImpediMed Limited (IPD.XA)September 23, 2024 | finance.yahoo.comQ2 2024 ImpediMed Ltd Activities Report Call TranscriptSeptember 14, 2024 | gurufocus.comHalf Year 2024 ImpediMed Ltd Earnings Call TranscriptSeptember 14, 2024 | gurufocus.comQ3 2024 ImpediMed Ltd Activities Report Call TranscriptSeptember 14, 2024 | gurufocus.comImpediMed Ltd Ordinary Shareholders Meeting TranscriptSeptember 14, 2024 | gurufocus.comFull Year 2024 ImpediMed Ltd Earnings Call TranscriptSeptember 14, 2024 | gurufocus.comImpedimed Ltd (ASX:IPD) Q4 2024 Earnings Call Transcript Highlights: Strong Core Business ...September 14, 2024 | gurufocus.comImpedimed Ltd (ASX:IPD) Q2 2024 Earnings Call Transcript Highlights: Key Takeaways and ...September 14, 2024 | gurufocus.comScoPo’s Powerplays: ASX health stocks fall in ‘lacklustre’ weekSeptember 6, 2024 | msn.comAugust Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’September 3, 2024 | msn.comImpedimed Ltd (IPD)September 3, 2024 | investing.comHealthInvest 2024 set to show off latest ASX healthcare innovatorsAugust 25, 2024 | msn.comMontana asbestos clinic seeks to reverse $6M in fines, penalties over false claimsAugust 21, 2024 | msn.comRising prices will prolong America's home-affordability crisis with 89% of the market still overvalued, Fitch saysAugust 21, 2024 | msn.comInvestors in ImpediMed (ASX:IPD) have unfortunately lost 74% over the last yearAugust 21, 2024 | finance.yahoo.comImpediMed's (ASX:IPD) investors will be pleased with their notable 72% return over the last yearMarch 14, 2024 | finance.yahoo.comSkin in the game: Which ASX director is betting on a lithium recovery?March 11, 2024 | msn.com Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPD Media Mentions By Week IPD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPD News Sentiment▼0.000.92▲Average Medical News Sentiment IPD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPD Articles This Week▼00▲IPD Articles Average Week Get the Latest News and Ratings for IPD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ImpediMed and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Hamilton Thorne News Stratec News NIOX Group News Profound Medical News Quipt Home Medical News EKF Diagnostics News Creo Medical Group News Theralase Technologies News Novacyt News MedX Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IPD) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImpediMed Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ImpediMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPD Stock Alerts